HKD8.28
1.60% today
Hong Kong, Jul 07, 03:45 am CET
ISIN
HK1093012172
Symbol
1093
Index
Sector
Industry

CSPC Pharmaceutical Group Limited Target price 2025 - Analyst rating & recommendation

CSPC Pharmaceutical Group Limited Classifications & Recommendation:

Buy
68%
Hold
26%
Sell
6%

CSPC Pharmaceutical Group Limited Price Target

Target Price HKD8.43
Price HKD8.15
Potential
Number of Estimates 27
27 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2026 . The average CSPC Pharmaceutical Group Limited target price is HKD8.43. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 31 analysts: 21 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 8 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2026 of . Most analysts recommend the CSPC Pharmaceutical Group Limited stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion HKD 31.78 34.30
7.76% 7.92%
EBITDA Margin 24.03% 26.22%
10.70% 9.11%

27 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2025 . The average CSPC Pharmaceutical Group Limited sales estimate is

HKD34.3b
Unlock
. This is
15.77% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD38.4b 29.77%
Unlock
, the lowest is
HKD30.9b 4.31%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD31.8b 7.76%
2025
HKD34.3b 7.92%
Unlock
2026
HKD35.0b 2.19%
Unlock
2027
HKD37.4b 6.67%
Unlock
2028
HKD34.6b 7.56%
Unlock
2029
HKD36.3b 5.01%
Unlock
2030
HKD38.1b 5.01%
Unlock
2031
HKD37.9b 0.47%
Unlock
2032
HKD39.6b 4.30%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share HKD 0.40 0.49
25.93% 22.50%
P/E 16.54

25 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited EPS is

HKD0.49
Unlock
. This is
25.64% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HKD0.64 64.10%
Unlock
, the lowest is
HKD0.35 10.26%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD0.40 25.93%
2025
HKD0.49 22.50%
Unlock
2026
HKD0.48 2.04%
Unlock
2027
HKD0.50 4.17%
Unlock
2028
HKD0.49 2.00%
Unlock
2029
HKD0.50 2.04%
Unlock
2030
HKD0.52 4.00%
Unlock
2031
HKD0.53 1.92%
Unlock
2032
HKD0.55 3.77%
Unlock

P/E ratio

Current 20.90 84.78%
2025
16.54 20.85%
Unlock
2026
16.83 1.75%
Unlock
2027
16.36 2.79%
Unlock
2028
16.65 1.77%
Unlock
2029
16.28 2.22%
Unlock
2030
15.58 4.30%
Unlock
2031
15.25 2.12%
Unlock
2032
14.94 2.03%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today